Scarica l'app Stockscreener
5.65
0.10%
0.0057
Precedente Chiudi:
$5.6443
Aprire:
$4.99
Volume 24 ore:
8,060
Relative Volume:
1.13
Capitalizzazione di mercato:
$93.57M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+14.11%
1M Prestazione:
-10.03%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$4.99
$5.65
Intervallo di 1 settimana:
$4.7237
$5.65
Portata 52W:
$4.7237
$6.85
Bioharvest Sciences Inc Stock (BHST) Company Profile
Nome
Bioharvest Sciences Inc
Settore
Industria
Telefono
-
Indirizzo
-
Confronta BHST con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BHST
Bioharvest Sciences Inc
|
5.65 | 93.57M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
489.01 | 125.39B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
721.10 | 79.10B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
669.71 | 40.58B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
275.24 | 35.43B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
122.10 | 29.34B | 3.30B | -501.07M | 1.03B | -2.1146 |
Bioharvest Sciences Inc Stock (BHST) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-18 | Iniziato | Maxim Group | Buy |
Bioharvest Sciences Inc Borsa (BHST) Ultime notizie
When Will BioHarvest Sciences Inc. (CSE:BHSC) Become Profitable? - Simply Wall St
BioHarvest Sciences reports material change - Investing.com India
BioHarvest Sciences Appoints Sharon Malka to Board of Directors - TipRanks
BioHarvest Sciences reports material change By Investing.com - Investing.com UK
BioHarvest Sciences appoints veteran technology leader to board of directors - Proactive Investors USA
BioHarvest Announces Appointment of Sharon Malka to Board of Directors - Newsfile
Bioharvest Sciences Inc. Appoints Sharon Malka as Independent Director -January 22, 2025 at 08:34 am EST - Marketscreener.com
OTC Markets Group Announces Quarterly Index Performance and Rebalancing - GlobeNewswire Inc.
BioHarvest Sciences Strengthens Board with Healthcare Industry Veteran Sharon Malka - StockTitan
BioHarvest Sciences positioned for ‘legacy year’ in 2025, building on momentum with new innovations and strategic collaborations - Proactive Investors USA
BioHarvest Sciences doubles VINIA business, eyes growth By Investing.com - Investing.com Australia
CSE Bulletin: NV Issuer DesignationBioHarvest Sciences Inc. (BHSC) - Newsfile
BioHarvest Sciences CEO reflects on transformative 2024, outlines vision for future growth - Proactive Investors UK
BioHarvest Sciences Unveils Strategic Growth Initiatives with New CDMO Division - TipRanks
BioHarvest Sciences doubles VINIA business, eyes growth - Investing.com
BioHarvest Issues Shareholder Letter and Provides Corporate Update - Yahoo Finance
BioHarvest Sciences (NASDAQ:BHST) Earns Buy Rating from Analysts at Maxim Group - Defense World
Maxim Group sets Buy rating on BioHarvest Sciences shares, cites robust growth - Investing.com India
BioHarvest Sciences (NASDAQ:BHST) Now Covered by Maxim Group - MarketBeat
BioHarvest Sciences CEO discusses Tate & Lyle partnershipICYMI - Proactive Investors USA
Clean the SkyBotanical Sweetener Partnerships - Trend Hunter
BioHarvest Sciences shares keep buy rating, partnership drives optimism By Investing.com - Investing.com South Africa
BioHarvest Sciences shares keep buy rating, partnership drives optimism - Investing.com India
Tate & Lyle and BioHarvest collaboration to pioneer next gen plant-based ingredients - Food and Drink Technology
BioHarvest Sciences Partners with Tate & Lyle to Develop Sustainable Plant-Based Sweeteners - Proactive Investors USA
BioHarvest Sciences partners with Tate & Lyle to advance plant-based sweeteners - Proactive Investors UK
EXCLUSIVE: BioHarvest Collaborate With Tate & Lyle To Develop Proprietary Plant-Based Molecules - AOL
Tate & Lyle and BioHarvest Announce Partnership to Drive the Future of Ingredients Through Botanical Synthesis Technology - Newsfile
Tate & Lyle Partners with BioHarvest Sciences to Revolutionize Plant-Based Sweeteners Using Breakthrough Technology - StockTitan
BHST News Today | Why did BioHarvest Sciences stock go up today? - MarketBeat
HC Wainwright Initiates Coverage on BioHarvest Sciences (NASDAQ:BHST) - Defense World
CNVCF (BioHarvest Sciences) GF Value Rank : 2 (As of Nov. 30, 2024) - GuruFocus.com
BioHarvest Sciences expands VINIA product line with launch of SuperFood Infused Teas - Proactive Investors Australia
BioHarvest Sciences Inc (CNVCF) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ... By GuruFocus - Investing.com Canada
BioHarvest Sciences Inc. (BHST) Reports Q3 Loss, Misses Revenue Estimates - MSN
BioHarvest Sciences Inc (CNVCF) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Expansion - GuruFocus.com
BioHarvest Sciences Inc (CNVCF) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo Finance
BioHarvest reports strong response from VINIA Superfood Coffee - Comunicaffe
BioHarvest Launches VINIA SuperFood Functional Tea Line - Sault This Week
Bioharvest Sciences Inc Azioni (BHST) Dati Finanziari
Non sono disponibili dati finanziari per Bioharvest Sciences Inc (BHST). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
1.57%
1.13%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):